MDNews - Lower Hudson/Bronx

October/November 2019

Issue link: https://viewer.e-digitaledition.com/i/1176730

Contents of this Issue

Navigation

Page 7 of 23

Dr. Rasamny uses a nerve monitoring system during parotidectomies and the removal of benign and malignant thyroid, parathyroid, and salivary gland tumors, as well as lymph nodes. While this system is not classified as an imaging technology, it allows him to avoid damaging nerves and more accurately determine which lymph nodes to remove during surgery. EXCEPTIONAL ENT EXPERTISE The ex pa nded Otola r y ngolog y tea m can perform many procedures that are unava i lable elsewhere in the Lower Hudson Valley and other communities north of New York City. These procedures include endoscopic skull base surgery for complex sinonasal and intracranial conditions, performed by Dr. Kamat, as well as TORS, performed by Dr. Rasamny. "Endoscopic skull base surgeons tend to gravitate toward academic positions in Manhattan," Dr. Kamat says. "That's why there are only two or three surgeons who can do these types of surgeries in the Hudson Valley, including myself." During skull base surgeries, Dr. Kamat uses the nose as a conduit to the skull and brain. He can create small openings in the rear portion of the nose to access and resect benign and malignant skull base tumors, such as those found on the pituitar y gland. In the past, this type of surgery required an open approach that was painful for patients and neces- sitated long recovery times. These open techniques include craniotomies, facial Drs. Berzofsky and Rasamny discuss a patient's treatment plan at White Plains Hospital Medical & Wellness in Armonk. Offices in Armonk, Somers and White Plains provide patients access to the team of expert physicians collaborating on complex care for ear, nose and throat disorders. degloving and brain retraction — pro- cedures that often result in significant scarring and an increased possibility of complications. "Open skull base surgery requires a full day in the OR and a hospital stay of one to two weeks," Dr. Kamat says. "With the minimally invasive approach through the nose, skull base surgeries now take four to six hours to complete and often two to three days of hospitalization. Pituitary surgeries are even shorter, lasting two to three hours at most. There are no cuts on the face, and the procedure is very safe." A CLOSER LOOK AT TORS Similar to the skull base surgeries that Dr. Kamat performs, TORS procedures focus on using another natural conduit — the mouth — to faci litate minima l ly invasive surgery, resulting in improved recovery times, fewer complications and improved outcomes for patients. TORS uses three robotic arms to visu- alize and remove tumors from the tonsils and tong ue base: One arm is equipped w it h a ca mera , a not her ser ves a s a grasper, and the third is equipped with a tool to resect the tumor. Dr. Rasamny operates a ll three arms from a surgica l console and collaborates with a patholo- gist to confirm successful resection of the entire tumor through the mouth. Afterward, sutures are used to close off any defects, and patients typically return home in two to three days. " Historica lly, sma ll ca ncers of the tonsils and tongue base were treated with chemotherapy and radiation, but because of technological advancements, surgery 0 8❱❱❱❱❱ C O V E R F E A T U R E

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - October/November 2019